IL-18 expression in pigs following infection with Mycoplasma hyopneumoniae

Journal of Interferon and Cytokine Research

Volumn 26, Issue 9, 2006, Pages 637-644

  Muneta, Yoshihiro ^a   Minagawa, Yu ^a   Shimoji, Yoshihiro ^a   Nagata, Reiko ^a   Markham, Philip F ^b   Browning, Glenn F ^b   Mori, Yasuyuki ^a  

^a NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 18 RECEPTOR ALPHA; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL INFECTION; FEMALE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IN VITRO STUDY; INNATE IMMUNITY; LUNG LAVAGE; MACROPHAGE ACTIVATION; MONONUCLEAR CELL; MYCOPLASMA HYOPNEUMONIAE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; SWINE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; DINOPROSTONE; FEMALE; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERLEUKIN-18; LUNG; MACROPHAGES; MYCOPLASMA HYOPNEUMONIAE; PLASMA CELLS; PNEUMONIA OF SWINE, MYCOPLASMAL; RECEPTORS, INTERLEUKIN-18; SWINE;

MYCOPLASMA HYOPNEUMONIAE; SUIDAE; SUS SCROFA;

EID: 33750630706     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.26.637     Document Type: Article

References (45)

1. Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Haruka A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, Akita K, Namba M, Tanabe F, Konishi K, Fukuda S, Kurimoto M. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 1995;378:88-91.
2. Hoshino T, Wiltrout RH, Young HA. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J. Immunol. 1999;162:5070-5077.
3. Yoshimoto T, Tsutsui H, Tominaga K, Hoshino K, Okamura H, Akira S, Paul WE, Nakanishi K. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc. Natl. Acad. Sci. USA 1999;96:13962-13966.
4. Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K, Tanabe F, Konishi K, Micallef M, Fujii M, Torigoe K, Tanimoto T, Fukuda S, Ikeda M, Okamura H, Kurimoto M. Cloning of the cDNA for human IFN-γ-inducing factor, expression in E. coli, and studies on the biological activities of the protein. J. Immunol. 1996;156:4274-4279.
5. Puren AJ, Fantuzzi G, Dinarello CA. Gene expression, synthesis and secretion of interleukin-18 and interleukin-1β are differentially regulated in human blood mononuclear cells and mouse spleen cells. Proc. Natl. Acad. Sci. USA 1999;96:2256-2261.
6. Stoll S, Muller G, Kurimoto M, Saloga J, Tanimoto T, Yamauchi H, Okamura H, Knop J, Enk A. Production of interferon-gamma-inducing factor (IGIF) mRNA and functional protein by murine keratinocytes. J. Immunol. 1997;159:298-302.
7. Gardella S, Andrei C, Constigliolo S, Poggi A, Zocchi MR, Rubartelli A. Interleukin-18 synthesis and secretion by dendritic cells are modulated by interaction with antigen-specific T cells. J. Leukoc. Biol. 1999;66:237-241.
8. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, Quintal L, Sekut L, Talanian R, Paskind M, Wong W, Kamen R, Tracey D, Allen H. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 1997;386:619-623.
9. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming M, Hayashi N, Higashino K, Okamura H, Nakanishi K, Kurimoto M, Tanimoto T, Flavell R, Sato V, Harding M, Livingston D, Su M. Activation of interferon-γ-inducing factor mediated by interleukin-1β converting enzyme. Science 1997;275:206-209.
10. Cameron LA, Taha RA, Tsicopoulos A, Kurimoto M, Olivenstein R, Wallaert B, Minshall EM, Hamid QA. Airway epithelium expresses interleukin-18. Eur. Respir. J. 1999;14:553-559.
11. Takeuchi M, Nishizaki Y, Sano O, Ohta T, Ikeda M, Kurimoto M. Immuno-histochemical detection of interferon-γ-inducing factor (IGIF)/interleukin-18 (IL-18) in mouse intestinal epithelial cells. Cell Tissue Res. 1997;289:499-503.
12. Muneta Y, Mori Y, Shimoji Y, Yokomizo Y. Porcine interleukin-18: cloning, characterization, and expression of the recombinant protein with baculovirus system. Cytokine 2000;12:566-572.
13. Shoda KM, Zarlenga DS, Hirano A, Brown WC. Cloning of a cDNA encoding bovine interleukin-18 and analysis of IL-18 expression in macrophages and its IFN-γ-inducing activity. J. Interferon Cytokine Res. 1999;19:1169-1177.
14. Nicolson L, Penha-Goncalves MN, Keanie JL, Logan NA, Argyle DJ, Onions DE. Cloning and sequencing of horse interleukin-12 and interleukin-18 cDNAs. Immunogenetics 1999;50:94-97.
15. Okano F, Satoh M, Ido T, Yamada K. Cloning of cDNA for canine interleukin-18 and canine interleukin-1β converting enzyme and expression of canine interleukin-18. J. Interferon Cytokine Res. 1999;19:27-32.
16. Ishizaka T, Setoguchi A, Masuda K, Ohno K, Tsujimoto H. Molecular cloning of feline interferon-γ-inducing factor (interleukin-18) and its expression in various tissues. Vet. Immunol. Immunopathol. 2001;79:209-218.
17. Muneta Y, Uenishi H, Yamamoto R, Yoshihara K, Yasue H, Awata T, Mori Y. Cloning, expression analyses, and chromosomal location of porcine interleukin-18 receptor α chain (IL-18Rα). J. Interferon Cytokine Res. 2002;22:995-1002.
18. Muneta Y, Shimoji Y, Yokomizo Y, Mori Y. Molecular cloning of porcine interleukin-1β converting enzyme and differential gene expression of interleukin-1β converting enzyme, interleukin-1β and interleukin-18 in porcine alveolar macrophages. J. Interferon Cytokine Res. 1999;19:1289-1296.
19. Muneta Y, Shimoji Y, Yokomizo Y, Mori Y. Production of monoclonal antibodies to porcine interleukin-18 and its application to the immunoaffinity purification of recombinant porcine interleukin-18. J. Immunol. Methods 2000;236:99-104.
20. Muneta Y, Mikami O, Shimoji Y, Nakajima Y, Yokomizo Y, Mori Y. Detection of porcine interleukin-18 by sandwich-ELISA and immunohistochemical staining using its monoclonal antibodies. J. Interferon Cytokine Res. 2000;20:331-336.
21. Ross RF. Mycoplasmal disease. In: Leman AD, Glock RD, Mengeling WL, Penny RHC, Scholl E, Straw B, eds. Swine Diseases. Ames, IA: Iowa State University Press, 1992:535-549.
22. Thacker EL, Halbur PG, Ross RF, Thanawongnuwech R, Thacker BJ. Mycoplasma hyopneumoniae potentiation of porcine reproductive and respiratory syndrome virus-induced pneumonia. J. Clin. Microbiol. 1999;37:620-627.
23. Kyriakis SC, Saoulidis K, Lekkas S, Miliotis CHC, Papoutsis PA, Kennedy S. The effects of immuno-modulation on the clinical and pathological expression of postweaning multisystemic wasting syndrome. J. Comp. Pathol. 2002;126:38-46.
24. Asai T, Okada M, Ono M, Irisawa T, Mori Y, Yokomizo Y, Sato S. Increased levels of tumor necrosis factor and interleukin-1 in bronchoalveolar lavage fluids from pigs infected with Mycoplasma hyopneumoniae. Vet. Immunol. Immunopathol. 1993;38:253-260.
25. 2 in bronchoalveolar lavage fluids of pigs experimentally infected with Mycoplasma hyopnemoniae. Vet. Immunol. Immunopathol. 1994;44:97-102.
26. Shimoji Y, Ohishi E, Kitajima T, Muneta Y, Shimizu S, Mori Y. Erysipelothrix rhusiopathiae YS-1 as a live vaccine vehicle for heterologous protein expression and intranasal immunization of pigs. Infect. Immun. 2002;70:226-232.
27. Shimoji Y, Ohishi E, Muneta Y, Nosaka H, Mori Y. Vaccine efficacy against swine mycoplasmal pneumonia of the attenuated Erysipelothrix rhusiopathiae YS-19 expressing a recombinant protein of Mycoplasma hyopneumoniae P97 adhesin. Vaccine 2003;21:532-537.
28. Mori Y, Yoshida Y, Kuniyasu C, Hashimoto K. Improvement of complement fixation test antigen for the diagnosis of Mycoplasma hyoneumoniae infection. Natl. Inst. Anim. Health Q (Tokyo) 1983;23:111-116.
29. Futo S, Seto Y, Okada M, Sato S, Suzuki T, Kawai K, Imada Y, Mori Y. Recombinant 46-kilodalton surface antigen (P46) of Mycoplasma hyopneumoniae expressed in Escherichia coli can be used for early specific diagnosis of mycoplasmal pneumoniae of swine by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 1995;33:680-683.
30. Narita M, Tanaka H, Abe S, Yamada S, Kubota M, Togashi T. Close association between pulmonary disease manifestation in Mycoplasma pnemoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon. Clin. Diagn. Lab. Immunol. 2000;7:909-914.
31. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 2001;12:53-72.
32. Tanaka H, Narita M, Teramoto S, Saikai T, Oashi K, Igarashi T, Abe S. Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults. Chest 2002;121:1493-1497.
33. Nuntaprasert A, Mori Y, Fujita K, Yoneda M, Miura R, Tsukiyama-Kohara K, Kai C. Characterization of specific antibodies and the establishment of sandwich ELISA and ELISPOT systems for swine IL-4. Comp. Immunol. Microbiol. Infect. Dis. 2004;27:457-470.
34. Okamoto M, Kato S, Oizumi K, Kinoshita M, Inoue Y, Hoshino K, Akira S, McKenzie ANJ, Young HA, Hoshino T. Interleukin-18 in synergy with IL-2 induces lethal lung injuries in mice: a potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of interstitial pneumonia. Blood 2002;99:1289-1298.
35. Blanchard B, Vena MM, Cavalier A, Lannic JL, Gouranton J, Kobisch M. Electron microscopic observation of the respiratory tract of SPF piglets inoculated with Mycoplasma hyopneumoniae. Vet. Microbiol. 1992;30:329-341.
36. Suter M, Kobisch M, Nicolet J. Stimulation of immunoglobulin-containing cells and isotype-specific antibody response in experimental Mycoplasma hyopneumoniae infection in specific-pathogen-free pigs. Infect. Immun. 1985;49:615-620.
37. Djordjevic SP, Eamens GJ, Romalis LF, Nicholls PJ, Taylor V, Chin J. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant. Aust. Vet. J. 1997;75:504-511.
38. Thacker EL, Thacker BJ, Kuhn M, Hawkins PA, Waters WR. Evaluation of local and systemic immune response induced by intramuscular injection of a Mycoplasma hyopneumoniae bacterin to pigs. Am. J. Vet. Res. 2000;61:1384-1389.
39. + T lymphocytes. AIDS Res. Hum. Retrovir. 1993;9:775-780.
40. Asai T, Okada M, Yokomizo Y, Sato S, Mori Y. Suppressive effect of bronchoalveolar fluid from pigs infected with Mycoplasma hyopneumoniae on chemiluminescence of porcine peripheral neutrophils. Vet. Immunol. Immunopathol. 1996;51:325-331.
41. Kashiwamura S, Ueda H, Okamura H. Roles of interleukin-18 in tissue destruction and compensatory reactions. J. Immunother. 2002;25:S4-S11.
42. 2 in radicular cysts. J. Maxillofac. Surg. 1986;14:108-112.
43. 2 regulation of the immune response. Adv. Prostaglandin Thromboxane Leukotriene Res. 1994;22:101-111.
44. 2 regulation of B lymphocytes and T helper 1 and T helper 2 cells: induction of inflammatory versus allergic responses. Adv. Exp. Med. Biol. 1997;407:237-242.
45. 2-mediated enhancement of human plasma cell differentiation. Immunol. Lett. 1982;4:113-116.